Our Services
Medical Information
Helpful Resources
Published on: 3/12/2026
Rituximab side effects occur because the drug depletes CD20-positive B cells, which shifts immune function and can trigger cytokine release. The most common side effects include infusion reactions, fatigue, rashes, and increased infection risk. Rare but serious risks include hepatitis B reactivation, low blood counts, heart or lung complications, and progressive multifocal leukoencephalopathy (PML).
Medically approved safety steps include hepatitis B screening, premedication before infusions, vaccinations before starting therapy, and regular lab monitoring. Patients should call their doctor for fever or infection signs, and seek emergency care for trouble breathing or chest pain.
Because rituximab side effects can range from mild fatigue to life-threatening reactions, knowing which symptoms need urgent attention is critical. A free, instant, online symptom check can help you evaluate your symptoms in minutes, understand possible causes, and guide your next steps—whether that's home monitoring, calling your doctor, or seeking emergency care.
Reviewed for medical accuracy: 07/10/2026
Not seeing your question? No worries.
Submit your own QuestionRituximab is a powerful medication used to treat several autoimmune diseases and certain cancers. It is commonly prescribed for:
While rituximab can be highly effective, it can also cause side effects. Understanding why these side effects happen — and what to do about them — can help you feel more informed and prepared.
Rituximab is a monoclonal antibody. It targets a protein called CD20 found on the surface of B cells, a type of white blood cell.
B cells are part of your immune system. In autoimmune diseases like rheumatoid arthritis, B cells mistakenly attack healthy tissue. Rituximab works by:
This process is helpful — but it also temporarily weakens part of your immune system. That immune shift explains many rituximab side effects.
Most people tolerate rituximab well. However, side effects can occur, especially during or shortly after infusions.
These usually happen during the first infusion and are often mild to moderate.
Symptoms may include:
Why it happens:
When rituximab binds to B cells, it can trigger the release of inflammatory chemicals (cytokines). This is sometimes called a cytokine release reaction.
What doctors do:
Most infusion reactions improve with these steps.
Because rituximab reduces B cells, your immune system becomes less effective at fighting certain infections.
Common infections include:
Less common but serious risks:
Doctors screen for hepatitis B before starting rituximab. This is standard practice and very important.
Rituximab can sometimes cause:
These changes may not cause symptoms but can increase infection or bleeding risk.
Regular blood tests are used to monitor this.
Many patients report feeling tired after rituximab infusions.
Possible reasons include:
Fatigue usually improves over time.
Some people experience:
If you notice blistering, peeling skin, or widespread rash, contact a doctor immediately.
In rare cases, rituximab may cause:
These require urgent medical attention.
Rituximab is often used for moderate to severe rheumatoid arthritis when other treatments have not worked.
In RA patients, common side effects include:
Because rheumatoid arthritis already affects the immune system, careful monitoring is especially important.
If you're experiencing unexplained joint pain, morning stiffness, or persistent swelling and aren't sure whether these symptoms could indicate Rheumatoid Arthritis (RA), a free AI-powered symptom assessment tool can help you understand your condition and determine the right time to seek medical care.
To understand rituximab side effects, it helps to understand immune balance.
When B cells are destroyed:
Your body reacts because it recognizes rapid immune change.
In most cases, the body adapts over time.
However, people with:
may have a higher risk of complications.
If you are experiencing rituximab side effects, here's what to do:
For mild issues like fatigue or minor rash:
Do not ignore symptoms — but mild reactions are often manageable.
Contact your healthcare provider if you develop:
Infections can progress faster in patients on rituximab.
Early treatment is important.
Go to the emergency room or call emergency services if you experience:
These could be life-threatening and require urgent medical attention.
Physicians follow evidence-based guidelines to improve safety.
These steps often include:
These strategies significantly reduce risk.
For many patients, rituximab provides major relief from autoimmune disease or cancer progression.
Long-term safety data show:
The benefits often outweigh the risks — but that decision is individualized.
You should always speak to a doctor if:
Anything that could be life-threatening or serious requires immediate medical evaluation.
Never stop rituximab without medical guidance.
Rituximab is a powerful and targeted therapy. Its side effects occur because it intentionally alters part of your immune system — specifically B cells. Most reactions are mild and manageable. Some are serious but rare.
Understanding the reasons behind these effects can help reduce fear while encouraging appropriate caution.
If you are living with rheumatoid arthritis or another autoimmune disease and considering rituximab, informed conversations with your healthcare provider are essential.
Monitor your symptoms. Keep your appointments. And always speak to a doctor about anything that could be serious or life-threatening.
With proper oversight, rituximab remains an important and often highly effective treatment option.
(References)
* Modi, M., & Vazirani, J. (2020). Adverse Events Associated With Rituximab and Their Management. *Journal of Clinical Hematology and Therapeutics*, *18*(4), 160-167. pubmed.ncbi.nlm.nih.gov/32675762/
* Tiu, T., Chen, Z., & Prystowsky, M. B. (2020). Rituximab-Associated Acute Infusion Reactions: A Review of Risk Factors, Mechanisms, and Management. *Annals of Pharmacotherapy*, *54*(8), 819-830. pubmed.ncbi.nlm.nih.gov/32098492/
* Chirmule, N., & Ryman, J. T. (2019). Immunogenicity of rituximab and its clinical implications. *Therapeutic Advances in Pharmacological Sciences*, *2*(1), 1-13. pubmed.ncbi.nlm.nih.gov/32676742/
* Laccetti, C., Scarlata, S., Saraceni, V., & Pedone, C. (2018). Management of infusion-related reactions to rituximab: a practical approach. *Journal of Asthma and Allergy*, *11*, 223-231. pubmed.ncbi.nlm.nih.gov/30498305/
* Park, J. H., Kim, Y. B., & Choi, S. H. (2021). Clinical Safety and Efficacy of Rituximab Biosimilars: An Update. *Biologics: Targets and Therapy*, *15*, 239-251. pubmed.ncbi.nlm.nih.gov/34295191/
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.